NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pat…
Medical - Diagnostics & Research
US, Fort Myers [HQ]
Cash Flow Statement
15 Sheets · From 2023 to 2009Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -1.00 | -2.00 | - - | - - | 2.00 | 9.00 | 6.00 | 21.00 | 18.00 | 44.00 | 23.00 | 1.00 | -26.00 | -65.00 | -1.00 | |
| Operating Cash (Net) | -1.00 | -2.00 | - - | - - | 2.00 | 9.00 | 6.00 | 21.00 | 18.00 | 44.00 | 23.00 | 1.00 | -26.00 | -65.00 | -1.00 | |
| Accounts Receivable | -3.00 | -2.00 | -5.00 | -9.00 | -7.00 | -2.00 | -3.00 | -18.00 | -24.00 | - - | -17.00 | -12.00 | -4.00 | -7.00 | -11.00 | |
| Accounts Payable | - - | - - | - - | 1.00 | - - | 2.00 | 5.00 | -2.00 | -4.00 | 12.00 | -9.00 | -3.00 | 5.00 | 2.00 | -4.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -3.00 | -3.00 | -3.00 | -8.00 | -7.00 | - - | -1.00 | -21.00 | -30.00 | 12.00 | -32.00 | -61.00 | -4.00 | -31.00 | -25.00 | |
| Other WC | - - | - - | 1.00 | - - | -1.00 | - - | -3.00 | - - | - - | -1.00 | - - | -29.00 | -6.00 | -25.00 | -8.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | - - | - - | - - | -3.00 | -2.00 | -9.00 | -75.00 | -6.00 | -13.00 | -139.00 | -19.00 | -159.00 | -632.00 | - - | 76.00 | |
| Capital Expenditure | - - | - - | - - | -3.00 | -2.00 | -3.00 | -2.00 | -7.00 | -13.00 | -14.00 | -20.00 | -29.00 | -64.00 | -30.00 | -28.00 | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -73.00 | -196.00 | -97.00 | -6.00 | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 5.00 | 62.00 | 116.00 | 112.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | -3.00 | -2.00 | -3.00 | -2.00 | -7.00 | -13.00 | -14.00 | -20.00 | -29.00 | -64.00 | -30.00 | -28.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | -5.00 | -72.00 | 1.00 | - - | -125.00 | - - | -62.00 | -419.00 | - - | -105.00 | |
| Other Investing Activities | - - | -916.00 | -897.00 | -1.00 | -2.00 | -9,602.00 | -72.00 | 1.00 | - - | - - | - - | -93.00 | -15.00 | 12.00 | 105.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -3.00 | -2.00 | -2.00 | -3.00 | -2.00 | -29.00 | -58.00 | -25.00 | -4.00 | -91.00 | -159.00 | -235.00 | -725.00 | -11.00 | -4.00 | |
| Debt Repayment | -1.00 | -1.00 | -1.00 | -2.00 | -6.00 | -7.00 | -4.00 | -60.00 | -9.00 | -11.00 | -111.00 | -103.00 | -3.00 | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | 59 | - - | 194 | - - | - - | - - | - - | - - | |
| Issued | 5.00 | - - | 3.00 | - - | 9.00 | 34.00 | 1.00 | 4.00 | 2.00 | 144.00 | 171.00 | 147.00 | 423.00 | 12.00 | 4.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | -55.00 | - - | -50.00 | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | 3.00 | - - | 5.00 | 2.00 | 2.00 | 61.00 | 173.00 | 2.00 | 18.00 | 98.00 | 191.00 | 305.00 | - - | - - | |
| Cash Balances | ||||||||||||||||
| Begin of Period | - - | 1.00 | 1.00 | 2.00 | 1.00 | 4.00 | 33.00 | 23.00 | 12.00 | 12.00 | 9.00 | 173.00 | 250.00 | 316.00 | 263.00 | |
| End of Period | 1.00 | 1.00 | 2.00 | 1.00 | 4.00 | 33.00 | 23.00 | 12.00 | 12.00 | 9.00 | 173.00 | 250.00 | 316.00 | 263.00 | 342.00 | |
| Change | 1.00 | - - | 1.00 | - - | 2.00 | 28.00 | -10.00 | -10.00 | - - | -3.00 | 163.00 | 77.00 | 66.00 | -53.00 | 79.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 1.00 | 1.00 | 2.00 | 3.00 | 4.00 | 5.00 | 7.00 | 23.00 | 22.00 | 21.00 | 30.00 | 35.00 | 53.00 | 69.00 | 72.00 | |
| Stock Based Compensation | - - | - - | - - | - - | - - | - - | 3.00 | 5.00 | 6.00 | - - | 10.00 | 10.00 | 22.00 | 24.00 | 24.00 | |
| Other | 2.00 | 2.00 | 2.00 | - - | - - | - - | 2.00 | 4.00 | - - | - - | 6.00 | 12.00 | 13.00 | 31.00 | 25.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -2.00 | -2.00 | - - | -4.00 | - - | 5.00 | 4.00 | 13.00 | 4.00 | 30.00 | 3.00 | -27.00 | -90.00 | -96.00 | -30.00 | |
| Cash Conversion Cycle (CCC) | 22.00 | 35.00 | 46.00 | 66.00 | 82.00 | 56.00 | 42.00 | 19.00 | 36.00 | 79.00 | 22.00 | 37.00 | 91.00 | 18.00 | 84.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |